Item 2.01.
Completion of Acquisition or Disposition of Assets.
On August 31, 2018 (the Closing Date), Penumbra, Inc. (the Company) acquired 40% of the outstanding shares of MVI Health Inc. (MVI), a privately-held company, from Sixense Enterprises, Inc. (Sixense), an unaffiliated privately-held company, pursuant to a Stock Transfer Agreement dated as of August 31, 2018 (the Transfer Agreement) by and between Penumbra and Sixense.
August 31, 2018
(the Closing Date), Penumbra, Inc. (the Company) acquired 40% of the outstanding shares of MVI Health Inc. (MVI), a privately-held company, from Sixense Enterprises, Inc. (Sixense), an unaffiliated privately-held company, pursuant to a Stock Transfer Agreement dated as of
August 31, 2018
(the Transfer Agreement) by and between Penumbra and Sixense.
MVI was formed in May of 2017 as a joint venture with Sixense for the purpose of exploring healthcare applications of virtual reality technology. The Company and Sixense each originally acquired a 50% interest in MVI. As of the Closing Date, the Company will own a 90% interest in MVI.
Pursuant to the terms of the Transfer Agreement, Penumbra paid Sixense $20.0 million in cash consideration on the Closing Date. The Transfer Agreement also contains an anti-dilution provision whereby the Company may issue additional shares of MVI to Sixense with an aggregate value up to $4.5 million.
The Transfer Agreement contains customary representations, warranties, covenants and indemnities of the parties to the agreement. Other than the transaction described above and the prior investment in MVI, there are no material relationships between the Company and Sixense.
Item 9.01.Financial Statements and Exhibits.
